trial · primary record
Bivamelagon
Hypothalamic Obesity
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 28 |
| Primary completion | 2026-02-09 |
| Primary endpoint | Treatment Phase: Mean Percentage Change From Baseline to Week 14 in Body Mass Index (BMI) |
| Registry ID | NCT06046443 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:14.614Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06046443
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.